- Home
- TLSA vs CCG Comparison
TLSA vs CCG Comparison
Compare TLSA & CCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TLSA | CCG |
|---|---|---|
| Founded | 2013 | 2014 |
| Country | United Kingdom | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 182.7M | 71.1M |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | TLSA | CCG |
|---|---|---|
| Price | $1.66 | $0.83 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $350.00 |
| AVG Volume (30 Days) | ★ 306.1K | 71.1K |
| Earning Date | 05-06-2025 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $444,290,042.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.63 | $0.71 |
| 52 Week High | $2.60 | $1.54 |
Technical Indicators
Market Signals| Indicator | TLSA | CCG |
|---|---|---|
| Relative Strength Index (RSI) | 55.53 | 44.06 |
| Support Level | $1.36 | $0.82 |
| Resistance Level | $1.58 | $0.88 |
| Average True Range (ATR) | 0.13 | 0.03 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 81.40 | 39.10 |
Price Performance
Historical ComparisonAbout TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.
About CCG Cheche Group Inc.
Cheche Group Inc is engaged in the operation of providing insurance transaction services, Software-as-a-Service (SaaS) services and other services in China.. It is China's independent technology-empowered platform for auto insurance transaction services by digital auto insurance transaction premiums and insurance technology companies. The company has reshaped the traditional auto insurance distribution and services value chain to create a digital platform by improving operational efficiencies, reducing transaction costs, and expanding distribution channels. Its business scope ranges from digital insurance transactions, SaaS platforms for insurance intermediaries, AI-driven insurance pricing and underwriting services, auto insurance services for new energy vehicle (NEV) manufacturers, etc.